Press releases

All press releases published by Fagron are available on this page.

Investors Press releases

Excellent year for Arseus: turnover increases 10.3% to EUR 391.3 million

Disclosure of received notification

Special shareholders’ meeting approves all motions

Disclosure of received notifications

Transactions between Waterland, Omega Pharma and Couckinvest completed

Omega Pharma sells 24.04% interest in Arseus for between 8.00 euro and a maximum of 10.75 euro per share

Disclosure of received notification

Arseus realises turnover growth of 8.3%

Strategic acquisition of Duo-Med in Belgium

Arseus appoints Sabine Sagaert as CEO of Arseus Dental